Compare
Onconetix, Inc. vs Hyperion Defi, Inc. vs Rallybio Corp vs Rafael Holdings, Inc.
| Latest fiscal year | Onconetix, Inc. ONCO | Hyperion Defi, Inc. HYPD | Rallybio Corp RLYB | Rafael Holdings, Inc. RFL |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-07-31 |
| Revenue | $815.4K | $813.5K | $858.0K | $917.0K |
| Revenue growth (YoY) | -67.7% | n/m | +34.9% | +44.0% |
| Gross margin | 77.6% | 62.7% | n/a | n/a |
| Operating margin | n/m | n/m | n/m | n/m |
| Net margin | n/m | n/m | n/m | n/m |
| Net income | -$14.03M | -$45.31M | -$8.98M | -$30.52M |
| EPS (Diluted) | -$16.56 | -$9.40 | -$1.59 | -$1.04 |
| Operating cash flow | -$9.68M | -$14.77M | -$29.81M | -$18.92M |
| Free cash flow | n/a | n/a | n/a | -$18.93M |
| Cash & equivalents | n/a | $6.44M | $31.37M | $52.77M |
| Total assets | $24.93M | $51.76M | $62.26M | $114.11M |
| Total liabilities | $9.16M | $10.70M | $4.30M | $15.74M |
| Shareholders' equity | $15.76M | $41.06M | $57.96M | $98.37M |
| Return on year-end equity | -89.0% | -110.4% | -15.5% | -31.0% |
| Shares outstanding | 1.56M | 8.68M | 5.28M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Onconetix, Inc. | Hyperion Defi, Inc. | Rallybio Corp | Rafael Holdings, Inc. |
|---|---|---|---|---|
| Latest | $815.4K Ended 2025-12-31 | $813.5K Ended 2025-12-31 | $858.0K Ended 2025-12-31 | $917.0K Ended 2025-07-31 |
| 1 year earlier | $2.52M Ended 2024-12-31 | $57.3K Ended 2024-12-31 | $636.0K Ended 2024-12-31 | $637.0K Ended 2024-07-31 |
| 2 years earlier | $58.5K Ended 2023-12-31 | $3.8K Ended 2023-12-31 | n/a | $279.0K Ended 2023-07-31 |
| 3 years earlier | n/a | n/a | n/a | $410.0K Ended 2022-07-31 |
| 4 years earlier | n/a | $14.00M Ended 2021-12-31 | n/a | $802.0K Ended 2021-07-31 |